GolinHarris delivers innovative approaches to healthcare communications by combining the best in consumer marketing and branding - a GH hallmark - with deep knowledge and experience in science, public policy and regulatory issues. The GolinHarris formula is simple, but powerful: combine analytical thinking and clinical understanding with creativity and consumer insights to develop programs that make a tangible difference.
We have extensive experience in the following areas:
- FDA/EMEA approvals, new indications for approved products
- Rx & OTC product launches, lifecycle management
- Medical meeting support, data promotion
- Patient and professional communications and education
- Coalition development, public health outreach and third-party partnerships
- Crisis communications and issues management
- Employee communications
- Brand and corporate image development
- Clinical trial recruitment
- Health policy
- Social marketing
GolinHarris strives to build trust among all its stakeholders by forging relationships with the people and organizations critical to our clients' success.
We have provided strategic counsel to a variety of leaders in healthcare, including:
Abbott Laboratories, Alcon, American Heart Association, American Lung Association, American Academy of Dermatology, Bayer Corporation, Bristol Myers-Squibb, Celltech Pharmaceuticals, Cord Blood Registry, GlaxoSmithKline, The Illinois Department of Public Health, Johnson & Johnson, Ortho-McNeil Neurologics, Inc., Piedmont Healthcare, Pfizer, Pharmacia, Prevent Blindness America, Shire Pharmaceuticals and Y-Me.
